COMMUNIQUÉS West-GlobeNewswire

Gyre Therapeutics Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
29/05/2025
SAN DIEGO, May 29, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems [...]
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
29/05/2025
LONDON, May 29, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will present at the following investor conferences in June: Jefferies 2025 Global [...]
Cytokinetics to Participate in the Jefferies Global Healthcare Conference
29/05/2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company’s management team are scheduled to participate in a fireside chat at [...]
Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
29/05/2025
WESTLAKE VILLAGE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
Theratechnologies Reports on its Annual Meeting of Shareholders
29/05/2025
MONTREAL, May 29, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, reported the voting results from its [...]
Theratechnologies rend compte de son assemblée annuelle des actionnaires
29/05/2025
MONTRÉAL, 29 mai 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial, a rapporté les résultats du vote [...]
NeuroOne to Attend MedInvest’s MedTech, AI & Digital Health Conference on June 3-4, 2025
29/05/2025
EDEN PRAIRIE, Minn., May 29, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
29/05/2025
VERAXA Attending ASCO and BIO with Cantor Fitzgerald, Voyager's Recently Retained Capital Markets Advisor, and Hosting Meetings with Potential Partners and Investors ZURICH, SWITZERLAND, May 29, 2025 -- VERAXA Biotech [...]
Basel Medical Group Ltd Reaffirms Strong Financial Position Amid Market Volatility
29/05/2025
Singapore, May 29, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”) , today reaffirmed the strength of its underlying financial performance and strategic outlook, despite recent [...]
Together we Walk at Breakthrough T1D Walk
29/05/2025
Throughout June close to 50 communities will be gathering across Canada to raise funds for type 1 diabetes research TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- Breakthrough T1D™ Walk (formerly JDRF Walk to Cure Diabetes) [...]
Ensemble, On Marche à la Marche Percée DT1
29/05/2025
Tout au long du mois de juin, près de 50 communautés se réuniront dans tout le Canada pour amasser des fonds en faveur de la recherche sur le diabète de type 1 TORONTO, 29 mai 2025 (GLOBE NEWSWIRE) -- La Marche Percée [...]
Sienna Senior Living Inc. Announces Results From Annual and Special Meeting
29/05/2025
MARKHAM, Ontario, May 29, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) is pleased to announce that it has received shareholder approval in respect of all resolutions to [...]
HealthEquity Community Foundation Awards $35,000 in New Grants
29/05/2025
From food banks to crisis shelters, 14 nonprofits recognized for tackling urgent community needs DRAPER, Utah, May 29, 2025 (GLOBE NEWSWIRE) -- The HealthEquity Community Foundation™ today announced the recipients of [...]
Akari Therapeutics Releases “Meet the Team” Video Featuring Recently Appointed Mark F. Kubik, Head of Business Development – Oncology
29/05/2025
Well-established industry leader whose oncology expertise and transactions record has led to multiple approved therapeutic products and advanced clinical product candidates Access the video here BOSTON and LONDON, May [...]
Positron Corporation Expands Market Presence with Sale of NeuSight PET-CT Scanner
29/05/2025
Niagara Falls, NY, May 29, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging systems and services, is pleased to announce the sale of its NeuSight PET [...]
Silexion Therapeutics Announces Groundbreaking Preclinical Results: SIL204 Shows Strong Efficacy in Pancreatic, Colorectal, and Lung Cancers
29/05/2025
Silexion’s Revolutionary RNAi approach demonstrates powerful anti-tumor activity across three major KRAS-driven cancer types; Inhibition rate of ~90% observed in GP2D human colorectal cancer cells; Company to conduct [...]
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors
29/05/2025
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the addition of healthcare veteran Elizabeth Bierbower to its [...]
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
29/05/2025
Southlake, TX, May 29, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”)-powered medical technology company focused on transforming [...]
Parexel Showcases Oncology Expertise at ASCO 2025; Company Selected to Present Five Posters at World’s Largest Oncology Event
29/05/2025
Parexel also launching a comprehensive Radiopharmaceuticals report at the meeting Onsite Parexel experts include recently appointed Chief Medical Officer and veteran oncologist Dr. Charlotte Moser, licensed medical [...]

Pages